Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4283734
Max Phase: Preclinical
Molecular Formula: C26H52N4O11
Molecular Weight: 596.72
Molecule Type: Small molecule
Associated Items:
ID: ALA4283734
Max Phase: Preclinical
Molecular Formula: C26H52N4O11
Molecular Weight: 596.72
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCO[C@@H]1[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](N)C[C@H](N)[C@H]1O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1N
Standard InChI: InChI=1S/C26H52N4O11/c1-2-3-4-5-6-7-8-37-24-22(40-25-16(30)19(34)17(32)14(10-27)38-25)12(28)9-13(29)23(24)41-26-21(36)20(35)18(33)15(11-31)39-26/h12-26,31-36H,2-11,27-30H2,1H3/t12-,13+,14+,15+,16+,17+,18+,19+,20-,21+,22+,23-,24-,25+,26+/m0/s1
Standard InChI Key: OHFBPVVVXICADV-NVUPSPOHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 596.72 | Molecular Weight (Monoisotopic): 596.3633 | AlogP: -3.91 | #Rotatable Bonds: 14 |
Polar Surface Area: 271.61 | Molecular Species: BASE | HBA: 15 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.14 | CX Basic pKa: 9.64 | CX LogP: -3.32 | CX LogD: -8.31 |
Aromatic Rings: 0 | Heavy Atoms: 41 | QED Weighted: 0.09 | Np Likeness Score: 1.29 |
1. Subedi YP, AlFindee MN, Takemoto JY, Chang CT.. (2018) Antifungal amphiphilic kanamycins: new life for an old drug., 9 (6): [PMID:30108980] [10.1039/C8MD00155C] |
Source(1):